Global Recombinant Hepatitis B Vaccine Market Growth 2023-2029
The report requires updating with new data and is sent in 48 hours after order is placed.
The hepatitis b vaccine is a vaccine against hepatitis b.That is, from hepatitis b virus carrier plasma isolation of hepatitis b surface antigen (HbsAg), after treatment and made.After second liver vaccine is inoculated, can stimulate immune system to produce protective antibody, this kind of antibody is in the humoral in the person, once second liver virus appears, antibody can act immediately, clear its, prevent infection, won't harm liver, make human body had the immunity that prevents second liver thereby.Therefore, hepatitis b vaccine has become an indispensable umbrella in life.Prevention generally lasts for at least 12 years, so there is no need for anti-hbs surveillance or enhanced immunity in the general population.However, anti-hbs surveillance can be carried out on high-risk groups, such as anti-hbs <10mIU/ml, which can be given enhanced immunity.
LPI (LP Information)' newest research report, the “Recombinant Hepatitis B Vaccine Industry Forecast” looks at past sales and reviews total world Recombinant Hepatitis B Vaccine sales in 2022, providing a comprehensive analysis by region and market sector of projected Recombinant Hepatitis B Vaccine sales for 2023 through 2029. With Recombinant Hepatitis B Vaccine sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Recombinant Hepatitis B Vaccine industry.
This Insight Report provides a comprehensive analysis of the global Recombinant Hepatitis B Vaccine landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Recombinant Hepatitis B Vaccine portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Recombinant Hepatitis B Vaccine market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Recombinant Hepatitis B Vaccine and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Recombinant Hepatitis B Vaccine.
The global Recombinant Hepatitis B Vaccine market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Recombinant Hepatitis B Vaccine is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Recombinant Hepatitis B Vaccine is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Recombinant Hepatitis B Vaccine is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Recombinant Hepatitis B Vaccine players cover Merck, GlaxoSmithKline Plc, Pfizer Inc., Sanofi Pasteur, CSL Limited, Emergent Biosolutions, Serum Institute of India, Johnson & Johnson and Hualan Biological Engineering, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Recombinant Hepatitis B Vaccine market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
What is the 10-year outlook for the global Recombinant Hepatitis B Vaccine market?
What factors are driving Recombinant Hepatitis B Vaccine market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Recombinant Hepatitis B Vaccine market opportunities vary by end market size?
How does Recombinant Hepatitis B Vaccine break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
The hepatitis b vaccine is a vaccine against hepatitis b.That is, from hepatitis b virus carrier plasma isolation of hepatitis b surface antigen (HbsAg), after treatment and made.After second liver vaccine is inoculated, can stimulate immune system to produce protective antibody, this kind of antibody is in the humoral in the person, once second liver virus appears, antibody can act immediately, clear its, prevent infection, won't harm liver, make human body had the immunity that prevents second liver thereby.Therefore, hepatitis b vaccine has become an indispensable umbrella in life.Prevention generally lasts for at least 12 years, so there is no need for anti-hbs surveillance or enhanced immunity in the general population.However, anti-hbs surveillance can be carried out on high-risk groups, such as anti-hbs <10mIU/ml, which can be given enhanced immunity.
LPI (LP Information)' newest research report, the “Recombinant Hepatitis B Vaccine Industry Forecast” looks at past sales and reviews total world Recombinant Hepatitis B Vaccine sales in 2022, providing a comprehensive analysis by region and market sector of projected Recombinant Hepatitis B Vaccine sales for 2023 through 2029. With Recombinant Hepatitis B Vaccine sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Recombinant Hepatitis B Vaccine industry.
This Insight Report provides a comprehensive analysis of the global Recombinant Hepatitis B Vaccine landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Recombinant Hepatitis B Vaccine portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Recombinant Hepatitis B Vaccine market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Recombinant Hepatitis B Vaccine and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Recombinant Hepatitis B Vaccine.
The global Recombinant Hepatitis B Vaccine market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Recombinant Hepatitis B Vaccine is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Recombinant Hepatitis B Vaccine is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Recombinant Hepatitis B Vaccine is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Recombinant Hepatitis B Vaccine players cover Merck, GlaxoSmithKline Plc, Pfizer Inc., Sanofi Pasteur, CSL Limited, Emergent Biosolutions, Serum Institute of India, Johnson & Johnson and Hualan Biological Engineering, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Recombinant Hepatitis B Vaccine market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
- 10mcg/ml
- 10mcg/0.5ml
- Newborn
- Primary School Students
- Adult
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Merck
- GlaxoSmithKline Plc
- Pfizer Inc.
- Sanofi Pasteur
- CSL Limited
- Emergent Biosolutions
- Serum Institute of India
- Johnson & Johnson
- Hualan Biological Engineering
- NCPC
- China National Biotec Group
- Dalian Hissen Bio-pharm
- Beijing Tiantan Biological
What is the 10-year outlook for the global Recombinant Hepatitis B Vaccine market?
What factors are driving Recombinant Hepatitis B Vaccine market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Recombinant Hepatitis B Vaccine market opportunities vary by end market size?
How does Recombinant Hepatitis B Vaccine break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Recombinant Hepatitis B Vaccine Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Recombinant Hepatitis B Vaccine by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Recombinant Hepatitis B Vaccine by Country/Region, 2018, 2022 & 2029
2.2 Recombinant Hepatitis B Vaccine Segment by Type
2.2.1 10mcg/ml
2.2.2 10mcg/0.5ml
2.3 Recombinant Hepatitis B Vaccine Sales by Type
2.3.1 Global Recombinant Hepatitis B Vaccine Sales Market Share by Type (2018-2023)
2.3.2 Global Recombinant Hepatitis B Vaccine Revenue and Market Share by Type (2018-2023)
2.3.3 Global Recombinant Hepatitis B Vaccine Sale Price by Type (2018-2023)
2.4 Recombinant Hepatitis B Vaccine Segment by Application
2.4.1 Newborn
2.4.2 Primary School Students
2.4.3 Adult
2.5 Recombinant Hepatitis B Vaccine Sales by Application
2.5.1 Global Recombinant Hepatitis B Vaccine Sale Market Share by Application (2018-2023)
2.5.2 Global Recombinant Hepatitis B Vaccine Revenue and Market Share by Application (2018-2023)
2.5.3 Global Recombinant Hepatitis B Vaccine Sale Price by Application (2018-2023)
3 GLOBAL RECOMBINANT HEPATITIS B VACCINE BY COMPANY
3.1 Global Recombinant Hepatitis B Vaccine Breakdown Data by Company
3.1.1 Global Recombinant Hepatitis B Vaccine Annual Sales by Company (2018-2023)
3.1.2 Global Recombinant Hepatitis B Vaccine Sales Market Share by Company (2018-2023)
3.2 Global Recombinant Hepatitis B Vaccine Annual Revenue by Company (2018-2023)
3.2.1 Global Recombinant Hepatitis B Vaccine Revenue by Company (2018-2023)
3.2.2 Global Recombinant Hepatitis B Vaccine Revenue Market Share by Company (2018-2023)
3.3 Global Recombinant Hepatitis B Vaccine Sale Price by Company
3.4 Key Manufacturers Recombinant Hepatitis B Vaccine Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Recombinant Hepatitis B Vaccine Product Location Distribution
3.4.2 Players Recombinant Hepatitis B Vaccine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR RECOMBINANT HEPATITIS B VACCINE BY GEOGRAPHIC REGION
4.1 World Historic Recombinant Hepatitis B Vaccine Market Size by Geographic Region (2018-2023)
4.1.1 Global Recombinant Hepatitis B Vaccine Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Recombinant Hepatitis B Vaccine Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Recombinant Hepatitis B Vaccine Market Size by Country/Region (2018-2023)
4.2.1 Global Recombinant Hepatitis B Vaccine Annual Sales by Country/Region (2018-2023)
4.2.2 Global Recombinant Hepatitis B Vaccine Annual Revenue by Country/Region (2018-2023)
4.3 Americas Recombinant Hepatitis B Vaccine Sales Growth
4.4 APAC Recombinant Hepatitis B Vaccine Sales Growth
4.5 Europe Recombinant Hepatitis B Vaccine Sales Growth
4.6 Middle East & Africa Recombinant Hepatitis B Vaccine Sales Growth
5 AMERICAS
5.1 Americas Recombinant Hepatitis B Vaccine Sales by Country
5.1.1 Americas Recombinant Hepatitis B Vaccine Sales by Country (2018-2023)
5.1.2 Americas Recombinant Hepatitis B Vaccine Revenue by Country (2018-2023)
5.2 Americas Recombinant Hepatitis B Vaccine Sales by Type
5.3 Americas Recombinant Hepatitis B Vaccine Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Recombinant Hepatitis B Vaccine Sales by Region
6.1.1 APAC Recombinant Hepatitis B Vaccine Sales by Region (2018-2023)
6.1.2 APAC Recombinant Hepatitis B Vaccine Revenue by Region (2018-2023)
6.2 APAC Recombinant Hepatitis B Vaccine Sales by Type
6.3 APAC Recombinant Hepatitis B Vaccine Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Recombinant Hepatitis B Vaccine by Country
7.1.1 Europe Recombinant Hepatitis B Vaccine Sales by Country (2018-2023)
7.1.2 Europe Recombinant Hepatitis B Vaccine Revenue by Country (2018-2023)
7.2 Europe Recombinant Hepatitis B Vaccine Sales by Type
7.3 Europe Recombinant Hepatitis B Vaccine Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Recombinant Hepatitis B Vaccine by Country
8.1.1 Middle East & Africa Recombinant Hepatitis B Vaccine Sales by Country (2018-2023)
8.1.2 Middle East & Africa Recombinant Hepatitis B Vaccine Revenue by Country (2018-2023)
8.2 Middle East & Africa Recombinant Hepatitis B Vaccine Sales by Type
8.3 Middle East & Africa Recombinant Hepatitis B Vaccine Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Recombinant Hepatitis B Vaccine
10.3 Manufacturing Process Analysis of Recombinant Hepatitis B Vaccine
10.4 Industry Chain Structure of Recombinant Hepatitis B Vaccine
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Recombinant Hepatitis B Vaccine Distributors
11.3 Recombinant Hepatitis B Vaccine Customer
12 WORLD FORECAST REVIEW FOR RECOMBINANT HEPATITIS B VACCINE BY GEOGRAPHIC REGION
12.1 Global Recombinant Hepatitis B Vaccine Market Size Forecast by Region
12.1.1 Global Recombinant Hepatitis B Vaccine Forecast by Region (2024-2029)
12.1.2 Global Recombinant Hepatitis B Vaccine Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Recombinant Hepatitis B Vaccine Forecast by Type
12.7 Global Recombinant Hepatitis B Vaccine Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Merck
13.1.1 Merck Company Information
13.1.2 Merck Recombinant Hepatitis B Vaccine Product Portfolios and Specifications
13.1.3 Merck Recombinant Hepatitis B Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Merck Main Business Overview
13.1.5 Merck Latest Developments
13.2 GlaxoSmithKline Plc
13.2.1 GlaxoSmithKline Plc Company Information
13.2.2 GlaxoSmithKline Plc Recombinant Hepatitis B Vaccine Product Portfolios and Specifications
13.2.3 GlaxoSmithKline Plc Recombinant Hepatitis B Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 GlaxoSmithKline Plc Main Business Overview
13.2.5 GlaxoSmithKline Plc Latest Developments
13.3 Pfizer Inc.
13.3.1 Pfizer Inc. Company Information
13.3.2 Pfizer Inc. Recombinant Hepatitis B Vaccine Product Portfolios and Specifications
13.3.3 Pfizer Inc. Recombinant Hepatitis B Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Pfizer Inc. Main Business Overview
13.3.5 Pfizer Inc. Latest Developments
13.4 Sanofi Pasteur
13.4.1 Sanofi Pasteur Company Information
13.4.2 Sanofi Pasteur Recombinant Hepatitis B Vaccine Product Portfolios and Specifications
13.4.3 Sanofi Pasteur Recombinant Hepatitis B Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Sanofi Pasteur Main Business Overview
13.4.5 Sanofi Pasteur Latest Developments
13.5 CSL Limited
13.5.1 CSL Limited Company Information
13.5.2 CSL Limited Recombinant Hepatitis B Vaccine Product Portfolios and Specifications
13.5.3 CSL Limited Recombinant Hepatitis B Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 CSL Limited Main Business Overview
13.5.5 CSL Limited Latest Developments
13.6 Emergent Biosolutions
13.6.1 Emergent Biosolutions Company Information
13.6.2 Emergent Biosolutions Recombinant Hepatitis B Vaccine Product Portfolios and Specifications
13.6.3 Emergent Biosolutions Recombinant Hepatitis B Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Emergent Biosolutions Main Business Overview
13.6.5 Emergent Biosolutions Latest Developments
13.7 Serum Institute of India
13.7.1 Serum Institute of India Company Information
13.7.2 Serum Institute of India Recombinant Hepatitis B Vaccine Product Portfolios and Specifications
13.7.3 Serum Institute of India Recombinant Hepatitis B Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Serum Institute of India Main Business Overview
13.7.5 Serum Institute of India Latest Developments
13.8 Johnson & Johnson
13.8.1 Johnson & Johnson Company Information
13.8.2 Johnson & Johnson Recombinant Hepatitis B Vaccine Product Portfolios and Specifications
13.8.3 Johnson & Johnson Recombinant Hepatitis B Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Johnson & Johnson Main Business Overview
13.8.5 Johnson & Johnson Latest Developments
13.9 Hualan Biological Engineering
13.9.1 Hualan Biological Engineering Company Information
13.9.2 Hualan Biological Engineering Recombinant Hepatitis B Vaccine Product Portfolios and Specifications
13.9.3 Hualan Biological Engineering Recombinant Hepatitis B Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Hualan Biological Engineering Main Business Overview
13.9.5 Hualan Biological Engineering Latest Developments
13.10 NCPC
13.10.1 NCPC Company Information
13.10.2 NCPC Recombinant Hepatitis B Vaccine Product Portfolios and Specifications
13.10.3 NCPC Recombinant Hepatitis B Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 NCPC Main Business Overview
13.10.5 NCPC Latest Developments
13.11 China National Biotec Group
13.11.1 China National Biotec Group Company Information
13.11.2 China National Biotec Group Recombinant Hepatitis B Vaccine Product Portfolios and Specifications
13.11.3 China National Biotec Group Recombinant Hepatitis B Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 China National Biotec Group Main Business Overview
13.11.5 China National Biotec Group Latest Developments
13.12 Dalian Hissen Bio-pharm
13.12.1 Dalian Hissen Bio-pharm Company Information
13.12.2 Dalian Hissen Bio-pharm Recombinant Hepatitis B Vaccine Product Portfolios and Specifications
13.12.3 Dalian Hissen Bio-pharm Recombinant Hepatitis B Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.12.4 Dalian Hissen Bio-pharm Main Business Overview
13.12.5 Dalian Hissen Bio-pharm Latest Developments
13.13 Beijing Tiantan Biological
13.13.1 Beijing Tiantan Biological Company Information
13.13.2 Beijing Tiantan Biological Recombinant Hepatitis B Vaccine Product Portfolios and Specifications
13.13.3 Beijing Tiantan Biological Recombinant Hepatitis B Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.13.4 Beijing Tiantan Biological Main Business Overview
13.13.5 Beijing Tiantan Biological Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Recombinant Hepatitis B Vaccine Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Recombinant Hepatitis B Vaccine by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Recombinant Hepatitis B Vaccine by Country/Region, 2018, 2022 & 2029
2.2 Recombinant Hepatitis B Vaccine Segment by Type
2.2.1 10mcg/ml
2.2.2 10mcg/0.5ml
2.3 Recombinant Hepatitis B Vaccine Sales by Type
2.3.1 Global Recombinant Hepatitis B Vaccine Sales Market Share by Type (2018-2023)
2.3.2 Global Recombinant Hepatitis B Vaccine Revenue and Market Share by Type (2018-2023)
2.3.3 Global Recombinant Hepatitis B Vaccine Sale Price by Type (2018-2023)
2.4 Recombinant Hepatitis B Vaccine Segment by Application
2.4.1 Newborn
2.4.2 Primary School Students
2.4.3 Adult
2.5 Recombinant Hepatitis B Vaccine Sales by Application
2.5.1 Global Recombinant Hepatitis B Vaccine Sale Market Share by Application (2018-2023)
2.5.2 Global Recombinant Hepatitis B Vaccine Revenue and Market Share by Application (2018-2023)
2.5.3 Global Recombinant Hepatitis B Vaccine Sale Price by Application (2018-2023)
3 GLOBAL RECOMBINANT HEPATITIS B VACCINE BY COMPANY
3.1 Global Recombinant Hepatitis B Vaccine Breakdown Data by Company
3.1.1 Global Recombinant Hepatitis B Vaccine Annual Sales by Company (2018-2023)
3.1.2 Global Recombinant Hepatitis B Vaccine Sales Market Share by Company (2018-2023)
3.2 Global Recombinant Hepatitis B Vaccine Annual Revenue by Company (2018-2023)
3.2.1 Global Recombinant Hepatitis B Vaccine Revenue by Company (2018-2023)
3.2.2 Global Recombinant Hepatitis B Vaccine Revenue Market Share by Company (2018-2023)
3.3 Global Recombinant Hepatitis B Vaccine Sale Price by Company
3.4 Key Manufacturers Recombinant Hepatitis B Vaccine Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Recombinant Hepatitis B Vaccine Product Location Distribution
3.4.2 Players Recombinant Hepatitis B Vaccine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR RECOMBINANT HEPATITIS B VACCINE BY GEOGRAPHIC REGION
4.1 World Historic Recombinant Hepatitis B Vaccine Market Size by Geographic Region (2018-2023)
4.1.1 Global Recombinant Hepatitis B Vaccine Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Recombinant Hepatitis B Vaccine Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Recombinant Hepatitis B Vaccine Market Size by Country/Region (2018-2023)
4.2.1 Global Recombinant Hepatitis B Vaccine Annual Sales by Country/Region (2018-2023)
4.2.2 Global Recombinant Hepatitis B Vaccine Annual Revenue by Country/Region (2018-2023)
4.3 Americas Recombinant Hepatitis B Vaccine Sales Growth
4.4 APAC Recombinant Hepatitis B Vaccine Sales Growth
4.5 Europe Recombinant Hepatitis B Vaccine Sales Growth
4.6 Middle East & Africa Recombinant Hepatitis B Vaccine Sales Growth
5 AMERICAS
5.1 Americas Recombinant Hepatitis B Vaccine Sales by Country
5.1.1 Americas Recombinant Hepatitis B Vaccine Sales by Country (2018-2023)
5.1.2 Americas Recombinant Hepatitis B Vaccine Revenue by Country (2018-2023)
5.2 Americas Recombinant Hepatitis B Vaccine Sales by Type
5.3 Americas Recombinant Hepatitis B Vaccine Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Recombinant Hepatitis B Vaccine Sales by Region
6.1.1 APAC Recombinant Hepatitis B Vaccine Sales by Region (2018-2023)
6.1.2 APAC Recombinant Hepatitis B Vaccine Revenue by Region (2018-2023)
6.2 APAC Recombinant Hepatitis B Vaccine Sales by Type
6.3 APAC Recombinant Hepatitis B Vaccine Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Recombinant Hepatitis B Vaccine by Country
7.1.1 Europe Recombinant Hepatitis B Vaccine Sales by Country (2018-2023)
7.1.2 Europe Recombinant Hepatitis B Vaccine Revenue by Country (2018-2023)
7.2 Europe Recombinant Hepatitis B Vaccine Sales by Type
7.3 Europe Recombinant Hepatitis B Vaccine Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Recombinant Hepatitis B Vaccine by Country
8.1.1 Middle East & Africa Recombinant Hepatitis B Vaccine Sales by Country (2018-2023)
8.1.2 Middle East & Africa Recombinant Hepatitis B Vaccine Revenue by Country (2018-2023)
8.2 Middle East & Africa Recombinant Hepatitis B Vaccine Sales by Type
8.3 Middle East & Africa Recombinant Hepatitis B Vaccine Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Recombinant Hepatitis B Vaccine
10.3 Manufacturing Process Analysis of Recombinant Hepatitis B Vaccine
10.4 Industry Chain Structure of Recombinant Hepatitis B Vaccine
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Recombinant Hepatitis B Vaccine Distributors
11.3 Recombinant Hepatitis B Vaccine Customer
12 WORLD FORECAST REVIEW FOR RECOMBINANT HEPATITIS B VACCINE BY GEOGRAPHIC REGION
12.1 Global Recombinant Hepatitis B Vaccine Market Size Forecast by Region
12.1.1 Global Recombinant Hepatitis B Vaccine Forecast by Region (2024-2029)
12.1.2 Global Recombinant Hepatitis B Vaccine Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Recombinant Hepatitis B Vaccine Forecast by Type
12.7 Global Recombinant Hepatitis B Vaccine Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Merck
13.1.1 Merck Company Information
13.1.2 Merck Recombinant Hepatitis B Vaccine Product Portfolios and Specifications
13.1.3 Merck Recombinant Hepatitis B Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Merck Main Business Overview
13.1.5 Merck Latest Developments
13.2 GlaxoSmithKline Plc
13.2.1 GlaxoSmithKline Plc Company Information
13.2.2 GlaxoSmithKline Plc Recombinant Hepatitis B Vaccine Product Portfolios and Specifications
13.2.3 GlaxoSmithKline Plc Recombinant Hepatitis B Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 GlaxoSmithKline Plc Main Business Overview
13.2.5 GlaxoSmithKline Plc Latest Developments
13.3 Pfizer Inc.
13.3.1 Pfizer Inc. Company Information
13.3.2 Pfizer Inc. Recombinant Hepatitis B Vaccine Product Portfolios and Specifications
13.3.3 Pfizer Inc. Recombinant Hepatitis B Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Pfizer Inc. Main Business Overview
13.3.5 Pfizer Inc. Latest Developments
13.4 Sanofi Pasteur
13.4.1 Sanofi Pasteur Company Information
13.4.2 Sanofi Pasteur Recombinant Hepatitis B Vaccine Product Portfolios and Specifications
13.4.3 Sanofi Pasteur Recombinant Hepatitis B Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Sanofi Pasteur Main Business Overview
13.4.5 Sanofi Pasteur Latest Developments
13.5 CSL Limited
13.5.1 CSL Limited Company Information
13.5.2 CSL Limited Recombinant Hepatitis B Vaccine Product Portfolios and Specifications
13.5.3 CSL Limited Recombinant Hepatitis B Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 CSL Limited Main Business Overview
13.5.5 CSL Limited Latest Developments
13.6 Emergent Biosolutions
13.6.1 Emergent Biosolutions Company Information
13.6.2 Emergent Biosolutions Recombinant Hepatitis B Vaccine Product Portfolios and Specifications
13.6.3 Emergent Biosolutions Recombinant Hepatitis B Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Emergent Biosolutions Main Business Overview
13.6.5 Emergent Biosolutions Latest Developments
13.7 Serum Institute of India
13.7.1 Serum Institute of India Company Information
13.7.2 Serum Institute of India Recombinant Hepatitis B Vaccine Product Portfolios and Specifications
13.7.3 Serum Institute of India Recombinant Hepatitis B Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Serum Institute of India Main Business Overview
13.7.5 Serum Institute of India Latest Developments
13.8 Johnson & Johnson
13.8.1 Johnson & Johnson Company Information
13.8.2 Johnson & Johnson Recombinant Hepatitis B Vaccine Product Portfolios and Specifications
13.8.3 Johnson & Johnson Recombinant Hepatitis B Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Johnson & Johnson Main Business Overview
13.8.5 Johnson & Johnson Latest Developments
13.9 Hualan Biological Engineering
13.9.1 Hualan Biological Engineering Company Information
13.9.2 Hualan Biological Engineering Recombinant Hepatitis B Vaccine Product Portfolios and Specifications
13.9.3 Hualan Biological Engineering Recombinant Hepatitis B Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Hualan Biological Engineering Main Business Overview
13.9.5 Hualan Biological Engineering Latest Developments
13.10 NCPC
13.10.1 NCPC Company Information
13.10.2 NCPC Recombinant Hepatitis B Vaccine Product Portfolios and Specifications
13.10.3 NCPC Recombinant Hepatitis B Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 NCPC Main Business Overview
13.10.5 NCPC Latest Developments
13.11 China National Biotec Group
13.11.1 China National Biotec Group Company Information
13.11.2 China National Biotec Group Recombinant Hepatitis B Vaccine Product Portfolios and Specifications
13.11.3 China National Biotec Group Recombinant Hepatitis B Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 China National Biotec Group Main Business Overview
13.11.5 China National Biotec Group Latest Developments
13.12 Dalian Hissen Bio-pharm
13.12.1 Dalian Hissen Bio-pharm Company Information
13.12.2 Dalian Hissen Bio-pharm Recombinant Hepatitis B Vaccine Product Portfolios and Specifications
13.12.3 Dalian Hissen Bio-pharm Recombinant Hepatitis B Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.12.4 Dalian Hissen Bio-pharm Main Business Overview
13.12.5 Dalian Hissen Bio-pharm Latest Developments
13.13 Beijing Tiantan Biological
13.13.1 Beijing Tiantan Biological Company Information
13.13.2 Beijing Tiantan Biological Recombinant Hepatitis B Vaccine Product Portfolios and Specifications
13.13.3 Beijing Tiantan Biological Recombinant Hepatitis B Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
13.13.4 Beijing Tiantan Biological Main Business Overview
13.13.5 Beijing Tiantan Biological Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Recombinant Hepatitis B Vaccine Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Recombinant Hepatitis B Vaccine Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of 10mcg/ml
Table 4. Major Players of 10mcg/0.5ml
Table 5. Global Recombinant Hepatitis B Vaccine Sales by Type (2018-2023) & (K Units)
Table 6. Global Recombinant Hepatitis B Vaccine Sales Market Share by Type (2018-2023)
Table 7. Global Recombinant Hepatitis B Vaccine Revenue by Type (2018-2023) & ($ million)
Table 8. Global Recombinant Hepatitis B Vaccine Revenue Market Share by Type (2018-2023)
Table 9. Global Recombinant Hepatitis B Vaccine Sale Price by Type (2018-2023) & (US$/Unit)
Table 10. Global Recombinant Hepatitis B Vaccine Sales by Application (2018-2023) & (K Units)
Table 11. Global Recombinant Hepatitis B Vaccine Sales Market Share by Application (2018-2023)
Table 12. Global Recombinant Hepatitis B Vaccine Revenue by Application (2018-2023)
Table 13. Global Recombinant Hepatitis B Vaccine Revenue Market Share by Application (2018-2023)
Table 14. Global Recombinant Hepatitis B Vaccine Sale Price by Application (2018-2023) & (US$/Unit)
Table 15. Global Recombinant Hepatitis B Vaccine Sales by Company (2018-2023) & (K Units)
Table 16. Global Recombinant Hepatitis B Vaccine Sales Market Share by Company (2018-2023)
Table 17. Global Recombinant Hepatitis B Vaccine Revenue by Company (2018-2023) ($ Millions)
Table 18. Global Recombinant Hepatitis B Vaccine Revenue Market Share by Company (2018-2023)
Table 19. Global Recombinant Hepatitis B Vaccine Sale Price by Company (2018-2023) & (US$/Unit)
Table 20. Key Manufacturers Recombinant Hepatitis B Vaccine Producing Area Distribution and Sales Area
Table 21. Players Recombinant Hepatitis B Vaccine Products Offered
Table 22. Recombinant Hepatitis B Vaccine Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Recombinant Hepatitis B Vaccine Sales by Geographic Region (2018-2023) & (K Units)
Table 26. Global Recombinant Hepatitis B Vaccine Sales Market Share Geographic Region (2018-2023)
Table 27. Global Recombinant Hepatitis B Vaccine Revenue by Geographic Region (2018-2023) & ($ millions)
Table 28. Global Recombinant Hepatitis B Vaccine Revenue Market Share by Geographic Region (2018-2023)
Table 29. Global Recombinant Hepatitis B Vaccine Sales by Country/Region (2018-2023) & (K Units)
Table 30. Global Recombinant Hepatitis B Vaccine Sales Market Share by Country/Region (2018-2023)
Table 31. Global Recombinant Hepatitis B Vaccine Revenue by Country/Region (2018-2023) & ($ millions)
Table 32. Global Recombinant Hepatitis B Vaccine Revenue Market Share by Country/Region (2018-2023)
Table 33. Americas Recombinant Hepatitis B Vaccine Sales by Country (2018-2023) & (K Units)
Table 34. Americas Recombinant Hepatitis B Vaccine Sales Market Share by Country (2018-2023)
Table 35. Americas Recombinant Hepatitis B Vaccine Revenue by Country (2018-2023) & ($ Millions)
Table 36. Americas Recombinant Hepatitis B Vaccine Revenue Market Share by Country (2018-2023)
Table 37. Americas Recombinant Hepatitis B Vaccine Sales by Type (2018-2023) & (K Units)
Table 38. Americas Recombinant Hepatitis B Vaccine Sales by Application (2018-2023) & (K Units)
Table 39. APAC Recombinant Hepatitis B Vaccine Sales by Region (2018-2023) & (K Units)
Table 40. APAC Recombinant Hepatitis B Vaccine Sales Market Share by Region (2018-2023)
Table 41. APAC Recombinant Hepatitis B Vaccine Revenue by Region (2018-2023) & ($ Millions)
Table 42. APAC Recombinant Hepatitis B Vaccine Revenue Market Share by Region (2018-2023)
Table 43. APAC Recombinant Hepatitis B Vaccine Sales by Type (2018-2023) & (K Units)
Table 44. APAC Recombinant Hepatitis B Vaccine Sales by Application (2018-2023) & (K Units)
Table 45. Europe Recombinant Hepatitis B Vaccine Sales by Country (2018-2023) & (K Units)
Table 46. Europe Recombinant Hepatitis B Vaccine Sales Market Share by Country (2018-2023)
Table 47. Europe Recombinant Hepatitis B Vaccine Revenue by Country (2018-2023) & ($ Millions)
Table 48. Europe Recombinant Hepatitis B Vaccine Revenue Market Share by Country (2018-2023)
Table 49. Europe Recombinant Hepatitis B Vaccine Sales by Type (2018-2023) & (K Units)
Table 50. Europe Recombinant Hepatitis B Vaccine Sales by Application (2018-2023) & (K Units)
Table 51. Middle East & Africa Recombinant Hepatitis B Vaccine Sales by Country (2018-2023) & (K Units)
Table 52. Middle East & Africa Recombinant Hepatitis B Vaccine Sales Market Share by Country (2018-2023)
Table 53. Middle East & Africa Recombinant Hepatitis B Vaccine Revenue by Country (2018-2023) & ($ Millions)
Table 54. Middle East & Africa Recombinant Hepatitis B Vaccine Revenue Market Share by Country (2018-2023)
Table 55. Middle East & Africa Recombinant Hepatitis B Vaccine Sales by Type (2018-2023) & (K Units)
Table 56. Middle East & Africa Recombinant Hepatitis B Vaccine Sales by Application (2018-2023) & (K Units)
Table 57. Key Market Drivers & Growth Opportunities of Recombinant Hepatitis B Vaccine
Table 58. Key Market Challenges & Risks of Recombinant Hepatitis B Vaccine
Table 59. Key Industry Trends of Recombinant Hepatitis B Vaccine
Table 60. Recombinant Hepatitis B Vaccine Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. Recombinant Hepatitis B Vaccine Distributors List
Table 63. Recombinant Hepatitis B Vaccine Customer List
Table 64. Global Recombinant Hepatitis B Vaccine Sales Forecast by Region (2024-2029) & (K Units)
Table 65. Global Recombinant Hepatitis B Vaccine Revenue Forecast by Region (2024-2029) & ($ millions)
Table 66. Americas Recombinant Hepatitis B Vaccine Sales Forecast by Country (2024-2029) & (K Units)
Table 67. Americas Recombinant Hepatitis B Vaccine Revenue Forecast by Country (2024-2029) & ($ millions)
Table 68. APAC Recombinant Hepatitis B Vaccine Sales Forecast by Region (2024-2029) & (K Units)
Table 69. APAC Recombinant Hepatitis B Vaccine Revenue Forecast by Region (2024-2029) & ($ millions)
Table 70. Europe Recombinant Hepatitis B Vaccine Sales Forecast by Country (2024-2029) & (K Units)
Table 71. Europe Recombinant Hepatitis B Vaccine Revenue Forecast by Country (2024-2029) & ($ millions)
Table 72. Middle East & Africa Recombinant Hepatitis B Vaccine Sales Forecast by Country (2024-2029) & (K Units)
Table 73. Middle East & Africa Recombinant Hepatitis B Vaccine Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Global Recombinant Hepatitis B Vaccine Sales Forecast by Type (2024-2029) & (K Units)
Table 75. Global Recombinant Hepatitis B Vaccine Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 76. Global Recombinant Hepatitis B Vaccine Sales Forecast by Application (2024-2029) & (K Units)
Table 77. Global Recombinant Hepatitis B Vaccine Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 78. Merck Basic Information, Recombinant Hepatitis B Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 79. Merck Recombinant Hepatitis B Vaccine Product Portfolios and Specifications
Table 80. Merck Recombinant Hepatitis B Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 81. Merck Main Business
Table 82. Merck Latest Developments
Table 83. GlaxoSmithKline Plc Basic Information, Recombinant Hepatitis B Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 84. GlaxoSmithKline Plc Recombinant Hepatitis B Vaccine Product Portfolios and Specifications
Table 85. GlaxoSmithKline Plc Recombinant Hepatitis B Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 86. GlaxoSmithKline Plc Main Business
Table 87. GlaxoSmithKline Plc Latest Developments
Table 88. Pfizer Inc. Basic Information, Recombinant Hepatitis B Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 89. Pfizer Inc. Recombinant Hepatitis B Vaccine Product Portfolios and Specifications
Table 90. Pfizer Inc. Recombinant Hepatitis B Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 91. Pfizer Inc. Main Business
Table 92. Pfizer Inc. Latest Developments
Table 93. Sanofi Pasteur Basic Information, Recombinant Hepatitis B Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 94. Sanofi Pasteur Recombinant Hepatitis B Vaccine Product Portfolios and Specifications
Table 95. Sanofi Pasteur Recombinant Hepatitis B Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 96. Sanofi Pasteur Main Business
Table 97. Sanofi Pasteur Latest Developments
Table 98. CSL Limited Basic Information, Recombinant Hepatitis B Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 99. CSL Limited Recombinant Hepatitis B Vaccine Product Portfolios and Specifications
Table 100. CSL Limited Recombinant Hepatitis B Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 101. CSL Limited Main Business
Table 102. CSL Limited Latest Developments
Table 103. Emergent Biosolutions Basic Information, Recombinant Hepatitis B Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 104. Emergent Biosolutions Recombinant Hepatitis B Vaccine Product Portfolios and Specifications
Table 105. Emergent Biosolutions Recombinant Hepatitis B Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 106. Emergent Biosolutions Main Business
Table 107. Emergent Biosolutions Latest Developments
Table 108. Serum Institute of India Basic Information, Recombinant Hepatitis B Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 109. Serum Institute of India Recombinant Hepatitis B Vaccine Product Portfolios and Specifications
Table 110. Serum Institute of India Recombinant Hepatitis B Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 111. Serum Institute of India Main Business
Table 112. Serum Institute of India Latest Developments
Table 113. Johnson & Johnson Basic Information, Recombinant Hepatitis B Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 114. Johnson & Johnson Recombinant Hepatitis B Vaccine Product Portfolios and Specifications
Table 115. Johnson & Johnson Recombinant Hepatitis B Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 116. Johnson & Johnson Main Business
Table 117. Johnson & Johnson Latest Developments
Table 118. Hualan Biological Engineering Basic Information, Recombinant Hepatitis B Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 119. Hualan Biological Engineering Recombinant Hepatitis B Vaccine Product Portfolios and Specifications
Table 120. Hualan Biological Engineering Recombinant Hepatitis B Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 121. Hualan Biological Engineering Main Business
Table 122. Hualan Biological Engineering Latest Developments
Table 123. NCPC Basic Information, Recombinant Hepatitis B Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 124. NCPC Recombinant Hepatitis B Vaccine Product Portfolios and Specifications
Table 125. NCPC Recombinant Hepatitis B Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 126. NCPC Main Business
Table 127. NCPC Latest Developments
Table 128. China National Biotec Group Basic Information, Recombinant Hepatitis B Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 129. China National Biotec Group Recombinant Hepatitis B Vaccine Product Portfolios and Specifications
Table 130. China National Biotec Group Recombinant Hepatitis B Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 131. China National Biotec Group Main Business
Table 132. China National Biotec Group Latest Developments
Table 133. Dalian Hissen Bio-pharm Basic Information, Recombinant Hepatitis B Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 134. Dalian Hissen Bio-pharm Recombinant Hepatitis B Vaccine Product Portfolios and Specifications
Table 135. Dalian Hissen Bio-pharm Recombinant Hepatitis B Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 136. Dalian Hissen Bio-pharm Main Business
Table 137. Dalian Hissen Bio-pharm Latest Developments
Table 138. Beijing Tiantan Biological Basic Information, Recombinant Hepatitis B Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 139. Beijing Tiantan Biological Recombinant Hepatitis B Vaccine Product Portfolios and Specifications
Table 140. Beijing Tiantan Biological Recombinant Hepatitis B Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 141. Beijing Tiantan Biological Main Business
Table 142. Beijing Tiantan Biological Latest Developments
Table 1. Recombinant Hepatitis B Vaccine Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Recombinant Hepatitis B Vaccine Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of 10mcg/ml
Table 4. Major Players of 10mcg/0.5ml
Table 5. Global Recombinant Hepatitis B Vaccine Sales by Type (2018-2023) & (K Units)
Table 6. Global Recombinant Hepatitis B Vaccine Sales Market Share by Type (2018-2023)
Table 7. Global Recombinant Hepatitis B Vaccine Revenue by Type (2018-2023) & ($ million)
Table 8. Global Recombinant Hepatitis B Vaccine Revenue Market Share by Type (2018-2023)
Table 9. Global Recombinant Hepatitis B Vaccine Sale Price by Type (2018-2023) & (US$/Unit)
Table 10. Global Recombinant Hepatitis B Vaccine Sales by Application (2018-2023) & (K Units)
Table 11. Global Recombinant Hepatitis B Vaccine Sales Market Share by Application (2018-2023)
Table 12. Global Recombinant Hepatitis B Vaccine Revenue by Application (2018-2023)
Table 13. Global Recombinant Hepatitis B Vaccine Revenue Market Share by Application (2018-2023)
Table 14. Global Recombinant Hepatitis B Vaccine Sale Price by Application (2018-2023) & (US$/Unit)
Table 15. Global Recombinant Hepatitis B Vaccine Sales by Company (2018-2023) & (K Units)
Table 16. Global Recombinant Hepatitis B Vaccine Sales Market Share by Company (2018-2023)
Table 17. Global Recombinant Hepatitis B Vaccine Revenue by Company (2018-2023) ($ Millions)
Table 18. Global Recombinant Hepatitis B Vaccine Revenue Market Share by Company (2018-2023)
Table 19. Global Recombinant Hepatitis B Vaccine Sale Price by Company (2018-2023) & (US$/Unit)
Table 20. Key Manufacturers Recombinant Hepatitis B Vaccine Producing Area Distribution and Sales Area
Table 21. Players Recombinant Hepatitis B Vaccine Products Offered
Table 22. Recombinant Hepatitis B Vaccine Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Recombinant Hepatitis B Vaccine Sales by Geographic Region (2018-2023) & (K Units)
Table 26. Global Recombinant Hepatitis B Vaccine Sales Market Share Geographic Region (2018-2023)
Table 27. Global Recombinant Hepatitis B Vaccine Revenue by Geographic Region (2018-2023) & ($ millions)
Table 28. Global Recombinant Hepatitis B Vaccine Revenue Market Share by Geographic Region (2018-2023)
Table 29. Global Recombinant Hepatitis B Vaccine Sales by Country/Region (2018-2023) & (K Units)
Table 30. Global Recombinant Hepatitis B Vaccine Sales Market Share by Country/Region (2018-2023)
Table 31. Global Recombinant Hepatitis B Vaccine Revenue by Country/Region (2018-2023) & ($ millions)
Table 32. Global Recombinant Hepatitis B Vaccine Revenue Market Share by Country/Region (2018-2023)
Table 33. Americas Recombinant Hepatitis B Vaccine Sales by Country (2018-2023) & (K Units)
Table 34. Americas Recombinant Hepatitis B Vaccine Sales Market Share by Country (2018-2023)
Table 35. Americas Recombinant Hepatitis B Vaccine Revenue by Country (2018-2023) & ($ Millions)
Table 36. Americas Recombinant Hepatitis B Vaccine Revenue Market Share by Country (2018-2023)
Table 37. Americas Recombinant Hepatitis B Vaccine Sales by Type (2018-2023) & (K Units)
Table 38. Americas Recombinant Hepatitis B Vaccine Sales by Application (2018-2023) & (K Units)
Table 39. APAC Recombinant Hepatitis B Vaccine Sales by Region (2018-2023) & (K Units)
Table 40. APAC Recombinant Hepatitis B Vaccine Sales Market Share by Region (2018-2023)
Table 41. APAC Recombinant Hepatitis B Vaccine Revenue by Region (2018-2023) & ($ Millions)
Table 42. APAC Recombinant Hepatitis B Vaccine Revenue Market Share by Region (2018-2023)
Table 43. APAC Recombinant Hepatitis B Vaccine Sales by Type (2018-2023) & (K Units)
Table 44. APAC Recombinant Hepatitis B Vaccine Sales by Application (2018-2023) & (K Units)
Table 45. Europe Recombinant Hepatitis B Vaccine Sales by Country (2018-2023) & (K Units)
Table 46. Europe Recombinant Hepatitis B Vaccine Sales Market Share by Country (2018-2023)
Table 47. Europe Recombinant Hepatitis B Vaccine Revenue by Country (2018-2023) & ($ Millions)
Table 48. Europe Recombinant Hepatitis B Vaccine Revenue Market Share by Country (2018-2023)
Table 49. Europe Recombinant Hepatitis B Vaccine Sales by Type (2018-2023) & (K Units)
Table 50. Europe Recombinant Hepatitis B Vaccine Sales by Application (2018-2023) & (K Units)
Table 51. Middle East & Africa Recombinant Hepatitis B Vaccine Sales by Country (2018-2023) & (K Units)
Table 52. Middle East & Africa Recombinant Hepatitis B Vaccine Sales Market Share by Country (2018-2023)
Table 53. Middle East & Africa Recombinant Hepatitis B Vaccine Revenue by Country (2018-2023) & ($ Millions)
Table 54. Middle East & Africa Recombinant Hepatitis B Vaccine Revenue Market Share by Country (2018-2023)
Table 55. Middle East & Africa Recombinant Hepatitis B Vaccine Sales by Type (2018-2023) & (K Units)
Table 56. Middle East & Africa Recombinant Hepatitis B Vaccine Sales by Application (2018-2023) & (K Units)
Table 57. Key Market Drivers & Growth Opportunities of Recombinant Hepatitis B Vaccine
Table 58. Key Market Challenges & Risks of Recombinant Hepatitis B Vaccine
Table 59. Key Industry Trends of Recombinant Hepatitis B Vaccine
Table 60. Recombinant Hepatitis B Vaccine Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. Recombinant Hepatitis B Vaccine Distributors List
Table 63. Recombinant Hepatitis B Vaccine Customer List
Table 64. Global Recombinant Hepatitis B Vaccine Sales Forecast by Region (2024-2029) & (K Units)
Table 65. Global Recombinant Hepatitis B Vaccine Revenue Forecast by Region (2024-2029) & ($ millions)
Table 66. Americas Recombinant Hepatitis B Vaccine Sales Forecast by Country (2024-2029) & (K Units)
Table 67. Americas Recombinant Hepatitis B Vaccine Revenue Forecast by Country (2024-2029) & ($ millions)
Table 68. APAC Recombinant Hepatitis B Vaccine Sales Forecast by Region (2024-2029) & (K Units)
Table 69. APAC Recombinant Hepatitis B Vaccine Revenue Forecast by Region (2024-2029) & ($ millions)
Table 70. Europe Recombinant Hepatitis B Vaccine Sales Forecast by Country (2024-2029) & (K Units)
Table 71. Europe Recombinant Hepatitis B Vaccine Revenue Forecast by Country (2024-2029) & ($ millions)
Table 72. Middle East & Africa Recombinant Hepatitis B Vaccine Sales Forecast by Country (2024-2029) & (K Units)
Table 73. Middle East & Africa Recombinant Hepatitis B Vaccine Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Global Recombinant Hepatitis B Vaccine Sales Forecast by Type (2024-2029) & (K Units)
Table 75. Global Recombinant Hepatitis B Vaccine Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 76. Global Recombinant Hepatitis B Vaccine Sales Forecast by Application (2024-2029) & (K Units)
Table 77. Global Recombinant Hepatitis B Vaccine Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 78. Merck Basic Information, Recombinant Hepatitis B Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 79. Merck Recombinant Hepatitis B Vaccine Product Portfolios and Specifications
Table 80. Merck Recombinant Hepatitis B Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 81. Merck Main Business
Table 82. Merck Latest Developments
Table 83. GlaxoSmithKline Plc Basic Information, Recombinant Hepatitis B Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 84. GlaxoSmithKline Plc Recombinant Hepatitis B Vaccine Product Portfolios and Specifications
Table 85. GlaxoSmithKline Plc Recombinant Hepatitis B Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 86. GlaxoSmithKline Plc Main Business
Table 87. GlaxoSmithKline Plc Latest Developments
Table 88. Pfizer Inc. Basic Information, Recombinant Hepatitis B Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 89. Pfizer Inc. Recombinant Hepatitis B Vaccine Product Portfolios and Specifications
Table 90. Pfizer Inc. Recombinant Hepatitis B Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 91. Pfizer Inc. Main Business
Table 92. Pfizer Inc. Latest Developments
Table 93. Sanofi Pasteur Basic Information, Recombinant Hepatitis B Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 94. Sanofi Pasteur Recombinant Hepatitis B Vaccine Product Portfolios and Specifications
Table 95. Sanofi Pasteur Recombinant Hepatitis B Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 96. Sanofi Pasteur Main Business
Table 97. Sanofi Pasteur Latest Developments
Table 98. CSL Limited Basic Information, Recombinant Hepatitis B Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 99. CSL Limited Recombinant Hepatitis B Vaccine Product Portfolios and Specifications
Table 100. CSL Limited Recombinant Hepatitis B Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 101. CSL Limited Main Business
Table 102. CSL Limited Latest Developments
Table 103. Emergent Biosolutions Basic Information, Recombinant Hepatitis B Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 104. Emergent Biosolutions Recombinant Hepatitis B Vaccine Product Portfolios and Specifications
Table 105. Emergent Biosolutions Recombinant Hepatitis B Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 106. Emergent Biosolutions Main Business
Table 107. Emergent Biosolutions Latest Developments
Table 108. Serum Institute of India Basic Information, Recombinant Hepatitis B Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 109. Serum Institute of India Recombinant Hepatitis B Vaccine Product Portfolios and Specifications
Table 110. Serum Institute of India Recombinant Hepatitis B Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 111. Serum Institute of India Main Business
Table 112. Serum Institute of India Latest Developments
Table 113. Johnson & Johnson Basic Information, Recombinant Hepatitis B Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 114. Johnson & Johnson Recombinant Hepatitis B Vaccine Product Portfolios and Specifications
Table 115. Johnson & Johnson Recombinant Hepatitis B Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 116. Johnson & Johnson Main Business
Table 117. Johnson & Johnson Latest Developments
Table 118. Hualan Biological Engineering Basic Information, Recombinant Hepatitis B Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 119. Hualan Biological Engineering Recombinant Hepatitis B Vaccine Product Portfolios and Specifications
Table 120. Hualan Biological Engineering Recombinant Hepatitis B Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 121. Hualan Biological Engineering Main Business
Table 122. Hualan Biological Engineering Latest Developments
Table 123. NCPC Basic Information, Recombinant Hepatitis B Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 124. NCPC Recombinant Hepatitis B Vaccine Product Portfolios and Specifications
Table 125. NCPC Recombinant Hepatitis B Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 126. NCPC Main Business
Table 127. NCPC Latest Developments
Table 128. China National Biotec Group Basic Information, Recombinant Hepatitis B Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 129. China National Biotec Group Recombinant Hepatitis B Vaccine Product Portfolios and Specifications
Table 130. China National Biotec Group Recombinant Hepatitis B Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 131. China National Biotec Group Main Business
Table 132. China National Biotec Group Latest Developments
Table 133. Dalian Hissen Bio-pharm Basic Information, Recombinant Hepatitis B Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 134. Dalian Hissen Bio-pharm Recombinant Hepatitis B Vaccine Product Portfolios and Specifications
Table 135. Dalian Hissen Bio-pharm Recombinant Hepatitis B Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 136. Dalian Hissen Bio-pharm Main Business
Table 137. Dalian Hissen Bio-pharm Latest Developments
Table 138. Beijing Tiantan Biological Basic Information, Recombinant Hepatitis B Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 139. Beijing Tiantan Biological Recombinant Hepatitis B Vaccine Product Portfolios and Specifications
Table 140. Beijing Tiantan Biological Recombinant Hepatitis B Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 141. Beijing Tiantan Biological Main Business
Table 142. Beijing Tiantan Biological Latest Developments
LIST OF FIGURES
Figure 1. Picture of Recombinant Hepatitis B Vaccine
Figure 2. Recombinant Hepatitis B Vaccine Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Recombinant Hepatitis B Vaccine Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Recombinant Hepatitis B Vaccine Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Recombinant Hepatitis B Vaccine Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of 10mcg/ml
Figure 10. Product Picture of 10mcg/0.5ml
Figure 11. Global Recombinant Hepatitis B Vaccine Sales Market Share by Type in 2022
Figure 12. Global Recombinant Hepatitis B Vaccine Revenue Market Share by Type (2018-2023)
Figure 13. Recombinant Hepatitis B Vaccine Consumed in Newborn
Figure 14. Global Recombinant Hepatitis B Vaccine Market: Newborn (2018-2023) & (K Units)
Figure 15. Recombinant Hepatitis B Vaccine Consumed in Primary School Students
Figure 16. Global Recombinant Hepatitis B Vaccine Market: Primary School Students (2018-2023) & (K Units)
Figure 17. Recombinant Hepatitis B Vaccine Consumed in Adult
Figure 18. Global Recombinant Hepatitis B Vaccine Market: Adult (2018-2023) & (K Units)
Figure 19. Global Recombinant Hepatitis B Vaccine Sales Market Share by Application (2022)
Figure 20. Global Recombinant Hepatitis B Vaccine Revenue Market Share by Application in 2022
Figure 21. Recombinant Hepatitis B Vaccine Sales Market by Company in 2022 (K Units)
Figure 22. Global Recombinant Hepatitis B Vaccine Sales Market Share by Company in 2022
Figure 23. Recombinant Hepatitis B Vaccine Revenue Market by Company in 2022 ($ Million)
Figure 24. Global Recombinant Hepatitis B Vaccine Revenue Market Share by Company in 2022
Figure 25. Global Recombinant Hepatitis B Vaccine Sales Market Share by Geographic Region (2018-2023)
Figure 26. Global Recombinant Hepatitis B Vaccine Revenue Market Share by Geographic Region in 2022
Figure 27. Americas Recombinant Hepatitis B Vaccine Sales 2018-2023 (K Units)
Figure 28. Americas Recombinant Hepatitis B Vaccine Revenue 2018-2023 ($ Millions)
Figure 29. APAC Recombinant Hepatitis B Vaccine Sales 2018-2023 (K Units)
Figure 30. APAC Recombinant Hepatitis B Vaccine Revenue 2018-2023 ($ Millions)
Figure 31. Europe Recombinant Hepatitis B Vaccine Sales 2018-2023 (K Units)
Figure 32. Europe Recombinant Hepatitis B Vaccine Revenue 2018-2023 ($ Millions)
Figure 33. Middle East & Africa Recombinant Hepatitis B Vaccine Sales 2018-2023 (K Units)
Figure 34. Middle East & Africa Recombinant Hepatitis B Vaccine Revenue 2018-2023 ($ Millions)
Figure 35. Americas Recombinant Hepatitis B Vaccine Sales Market Share by Country in 2022
Figure 36. Americas Recombinant Hepatitis B Vaccine Revenue Market Share by Country in 2022
Figure 37. Americas Recombinant Hepatitis B Vaccine Sales Market Share by Type (2018-2023)
Figure 38. Americas Recombinant Hepatitis B Vaccine Sales Market Share by Application (2018-2023)
Figure 39. United States Recombinant Hepatitis B Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 40. Canada Recombinant Hepatitis B Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 41. Mexico Recombinant Hepatitis B Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 42. Brazil Recombinant Hepatitis B Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 43. APAC Recombinant Hepatitis B Vaccine Sales Market Share by Region in 2022
Figure 44. APAC Recombinant Hepatitis B Vaccine Revenue Market Share by Regions in 2022
Figure 45. APAC Recombinant Hepatitis B Vaccine Sales Market Share by Type (2018-2023)
Figure 46. APAC Recombinant Hepatitis B Vaccine Sales Market Share by Application (2018-2023)
Figure 47. China Recombinant Hepatitis B Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 48. Japan Recombinant Hepatitis B Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 49. South Korea Recombinant Hepatitis B Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 50. Southeast Asia Recombinant Hepatitis B Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 51. India Recombinant Hepatitis B Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 52. Australia Recombinant Hepatitis B Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 53. China Taiwan Recombinant Hepatitis B Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 54. Europe Recombinant Hepatitis B Vaccine Sales Market Share by Country in 2022
Figure 55. Europe Recombinant Hepatitis B Vaccine Revenue Market Share by Country in 2022
Figure 56. Europe Recombinant Hepatitis B Vaccine Sales Market Share by Type (2018-2023)
Figure 57. Europe Recombinant Hepatitis B Vaccine Sales Market Share by Application (2018-2023)
Figure 58. Germany Recombinant Hepatitis B Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 59. France Recombinant Hepatitis B Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 60. UK Recombinant Hepatitis B Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 61. Italy Recombinant Hepatitis B Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 62. Russia Recombinant Hepatitis B Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 63. Middle East & Africa Recombinant Hepatitis B Vaccine Sales Market Share by Country in 2022
Figure 64. Middle East & Africa Recombinant Hepatitis B Vaccine Revenue Market Share by Country in 2022
Figure 65. Middle East & Africa Recombinant Hepatitis B Vaccine Sales Market Share by Type (2018-2023)
Figure 66. Middle East & Africa Recombinant Hepatitis B Vaccine Sales Market Share by Application (2018-2023)
Figure 67. Egypt Recombinant Hepatitis B Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 68. South Africa Recombinant Hepatitis B Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 69. Israel Recombinant Hepatitis B Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 70. Turkey Recombinant Hepatitis B Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 71. GCC Country Recombinant Hepatitis B Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 72. Manufacturing Cost Structure Analysis of Recombinant Hepatitis B Vaccine in 2022
Figure 73. Manufacturing Process Analysis of Recombinant Hepatitis B Vaccine
Figure 74. Industry Chain Structure of Recombinant Hepatitis B Vaccine
Figure 75. Channels of Distribution
Figure 76. Global Recombinant Hepatitis B Vaccine Sales Market Forecast by Region (2024-2029)
Figure 77. Global Recombinant Hepatitis B Vaccine Revenue Market Share Forecast by Region (2024-2029)
Figure 78. Global Recombinant Hepatitis B Vaccine Sales Market Share Forecast by Type (2024-2029)
Figure 79. Global Recombinant Hepatitis B Vaccine Revenue Market Share Forecast by Type (2024-2029)
Figure 80. Global Recombinant Hepatitis B Vaccine Sales Market Share Forecast by Application (2024-2029)
Figure 81. Global Recombinant Hepatitis B Vaccine Revenue Market Share Forecast by Application (2024-2029)
Figure 1. Picture of Recombinant Hepatitis B Vaccine
Figure 2. Recombinant Hepatitis B Vaccine Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Recombinant Hepatitis B Vaccine Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Recombinant Hepatitis B Vaccine Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Recombinant Hepatitis B Vaccine Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of 10mcg/ml
Figure 10. Product Picture of 10mcg/0.5ml
Figure 11. Global Recombinant Hepatitis B Vaccine Sales Market Share by Type in 2022
Figure 12. Global Recombinant Hepatitis B Vaccine Revenue Market Share by Type (2018-2023)
Figure 13. Recombinant Hepatitis B Vaccine Consumed in Newborn
Figure 14. Global Recombinant Hepatitis B Vaccine Market: Newborn (2018-2023) & (K Units)
Figure 15. Recombinant Hepatitis B Vaccine Consumed in Primary School Students
Figure 16. Global Recombinant Hepatitis B Vaccine Market: Primary School Students (2018-2023) & (K Units)
Figure 17. Recombinant Hepatitis B Vaccine Consumed in Adult
Figure 18. Global Recombinant Hepatitis B Vaccine Market: Adult (2018-2023) & (K Units)
Figure 19. Global Recombinant Hepatitis B Vaccine Sales Market Share by Application (2022)
Figure 20. Global Recombinant Hepatitis B Vaccine Revenue Market Share by Application in 2022
Figure 21. Recombinant Hepatitis B Vaccine Sales Market by Company in 2022 (K Units)
Figure 22. Global Recombinant Hepatitis B Vaccine Sales Market Share by Company in 2022
Figure 23. Recombinant Hepatitis B Vaccine Revenue Market by Company in 2022 ($ Million)
Figure 24. Global Recombinant Hepatitis B Vaccine Revenue Market Share by Company in 2022
Figure 25. Global Recombinant Hepatitis B Vaccine Sales Market Share by Geographic Region (2018-2023)
Figure 26. Global Recombinant Hepatitis B Vaccine Revenue Market Share by Geographic Region in 2022
Figure 27. Americas Recombinant Hepatitis B Vaccine Sales 2018-2023 (K Units)
Figure 28. Americas Recombinant Hepatitis B Vaccine Revenue 2018-2023 ($ Millions)
Figure 29. APAC Recombinant Hepatitis B Vaccine Sales 2018-2023 (K Units)
Figure 30. APAC Recombinant Hepatitis B Vaccine Revenue 2018-2023 ($ Millions)
Figure 31. Europe Recombinant Hepatitis B Vaccine Sales 2018-2023 (K Units)
Figure 32. Europe Recombinant Hepatitis B Vaccine Revenue 2018-2023 ($ Millions)
Figure 33. Middle East & Africa Recombinant Hepatitis B Vaccine Sales 2018-2023 (K Units)
Figure 34. Middle East & Africa Recombinant Hepatitis B Vaccine Revenue 2018-2023 ($ Millions)
Figure 35. Americas Recombinant Hepatitis B Vaccine Sales Market Share by Country in 2022
Figure 36. Americas Recombinant Hepatitis B Vaccine Revenue Market Share by Country in 2022
Figure 37. Americas Recombinant Hepatitis B Vaccine Sales Market Share by Type (2018-2023)
Figure 38. Americas Recombinant Hepatitis B Vaccine Sales Market Share by Application (2018-2023)
Figure 39. United States Recombinant Hepatitis B Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 40. Canada Recombinant Hepatitis B Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 41. Mexico Recombinant Hepatitis B Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 42. Brazil Recombinant Hepatitis B Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 43. APAC Recombinant Hepatitis B Vaccine Sales Market Share by Region in 2022
Figure 44. APAC Recombinant Hepatitis B Vaccine Revenue Market Share by Regions in 2022
Figure 45. APAC Recombinant Hepatitis B Vaccine Sales Market Share by Type (2018-2023)
Figure 46. APAC Recombinant Hepatitis B Vaccine Sales Market Share by Application (2018-2023)
Figure 47. China Recombinant Hepatitis B Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 48. Japan Recombinant Hepatitis B Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 49. South Korea Recombinant Hepatitis B Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 50. Southeast Asia Recombinant Hepatitis B Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 51. India Recombinant Hepatitis B Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 52. Australia Recombinant Hepatitis B Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 53. China Taiwan Recombinant Hepatitis B Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 54. Europe Recombinant Hepatitis B Vaccine Sales Market Share by Country in 2022
Figure 55. Europe Recombinant Hepatitis B Vaccine Revenue Market Share by Country in 2022
Figure 56. Europe Recombinant Hepatitis B Vaccine Sales Market Share by Type (2018-2023)
Figure 57. Europe Recombinant Hepatitis B Vaccine Sales Market Share by Application (2018-2023)
Figure 58. Germany Recombinant Hepatitis B Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 59. France Recombinant Hepatitis B Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 60. UK Recombinant Hepatitis B Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 61. Italy Recombinant Hepatitis B Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 62. Russia Recombinant Hepatitis B Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 63. Middle East & Africa Recombinant Hepatitis B Vaccine Sales Market Share by Country in 2022
Figure 64. Middle East & Africa Recombinant Hepatitis B Vaccine Revenue Market Share by Country in 2022
Figure 65. Middle East & Africa Recombinant Hepatitis B Vaccine Sales Market Share by Type (2018-2023)
Figure 66. Middle East & Africa Recombinant Hepatitis B Vaccine Sales Market Share by Application (2018-2023)
Figure 67. Egypt Recombinant Hepatitis B Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 68. South Africa Recombinant Hepatitis B Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 69. Israel Recombinant Hepatitis B Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 70. Turkey Recombinant Hepatitis B Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 71. GCC Country Recombinant Hepatitis B Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 72. Manufacturing Cost Structure Analysis of Recombinant Hepatitis B Vaccine in 2022
Figure 73. Manufacturing Process Analysis of Recombinant Hepatitis B Vaccine
Figure 74. Industry Chain Structure of Recombinant Hepatitis B Vaccine
Figure 75. Channels of Distribution
Figure 76. Global Recombinant Hepatitis B Vaccine Sales Market Forecast by Region (2024-2029)
Figure 77. Global Recombinant Hepatitis B Vaccine Revenue Market Share Forecast by Region (2024-2029)
Figure 78. Global Recombinant Hepatitis B Vaccine Sales Market Share Forecast by Type (2024-2029)
Figure 79. Global Recombinant Hepatitis B Vaccine Revenue Market Share Forecast by Type (2024-2029)
Figure 80. Global Recombinant Hepatitis B Vaccine Sales Market Share Forecast by Application (2024-2029)
Figure 81. Global Recombinant Hepatitis B Vaccine Revenue Market Share Forecast by Application (2024-2029)
